Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ABT-719, ZP1480 (formerly AP214)
print preview
bookmark
share with colleague
General Information
Company
Zealand Pharma A/S
Description
Alpha-melanocyte-stimulating hormone analog
Molecular Target
Melanocortin 1 receptor (MC1R)
;
Melanocortin 3 receptor (MC3R)
Mechanism of Action
Melanocortin 1 receptor (MC1R) agonist
Latest Stage of Development
Phase II
Indication
Renal damage
Partner
AbbVie Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy